RenovoRx Raises Funds and Awareness to Fight World’s Toughest Cancer
RenovoRx announced today it will join the Pancreatic Cancer Action Network (PanCAN) as a Silver Sponsor of the organization’s PurpleStride® Silicon Valley event to end pancreatic cancer.
RenovoRx Raises Funds and Awareness to Fight World’s Toughest Cancer
RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is reporting its financial results for the year ended December 31, 2021.
Late-Stage Clinical Biopharmaceutical Company with Novel Therapy Platform to Treat Locally Advanced Solid Tumors Presented at ROTH Capital Partners 34th Annual Conference, March 2022
https://renovorx.com/wp-content/uploads/2022/03/RNXT-Investor-Presentation_2022-03-14_2-animation-removed.pdf